Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Farhat Nasim

Farhat Nasim joined Medical Dialogue an Editor for the Business Section in 2017. She Covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She is a graduate of St.Xavier’s College Ranchi. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Farhat Nasim

Articles By : Farhat Nasim

DCGI Pushes Fast-Track Approval for Rare Disease Drugs, Prioritizes Patient Access

Farhat Nasim13 Dec 2024 6:28 PM IST

New Delhi: The Drug Controller General of India (DCGI) has instructed state and Union Territory drug controllers to fast-track the approval process...

UP Doctor sentenced to life imprisonment for raping nurse and abetting suicide

Drug controller gets 3-year jail, Rs 7L fine for amassing illicit wealth including silver artefacts, liquor

Farhat Nasim12 Dec 2024 5:56 PM IST

Dhiman also co-founded Lyra Lab Pvt Ltd, in Baddi, involving his nephew, with properties registered under his father's name in Panchkula and Mandi.

Delhi HC Orders Arbitration in Medikabazaar Board Dispute, Tiwari Challenges Termination

Cardiocontin vs. Nitrocontin: Delhi HC Warns of Life-Threatening Confusion Over Pharma Trademarks

Farhat Nasim11 Dec 2024 5:12 PM IST

New Delhi: The Delhi High Court has raised concerns over the potential risk of consumer confusion between the trademarks of Modi-Mundipharma Pvt....

NPPA Mandates Transparency in Angioplasty Billing with Separate Costs for Non-Stent Components: MoS Anupriya Patel

Farhat Nasim10 Dec 2024 3:04 PM IST

New Delhi: The National Pharmaceutical Pricing Authority (NPPA) mandates for hospitals performing angioplasty to itemize billing costs for non-stent...

CDSCO Waives Local Clinical Trials for Drugs Approved in Select Countries: Health Minister

Farhat Nasim9 Dec 2024 5:19 PM IST

New Delhi: All new drugs are approved by the Central Drugs Standard Control Organization (CDSCO) without local clinical trials on case to case basis...

FIR Against Aurobindo Pharma Official, Others for Alleged Rs 3,600 Crore Share Acquisition Scam

Farhat Nasim6 Dec 2024 4:08 PM IST

Vijayawada: The non-executive director of Aurobindo Pharma, Penaka Sarathchandra Reddy has come under scrutiny by the Crime Investigation Department...

JnJ seeks indication extension of Akeega from EMA for adults with metastatic hormone-sensitive prostate cancer, HRR gene alterations

Health Ministry Reconstitutes Expert Panel for J&J ASR Hip Implant Compensation

Farhat Nasim6 Dec 2024 4:06 PM IST

New Delhi: The Ministry of Health and Family Welfare has reconstituted its Central Expert Committee to address compensation issues concerning faulty...

116 pharma firms face strict penalties over substandard drugs

Farhat Nasim6 Dec 2024 4:05 PM IST

Shimla: In a significant move aimed at maintaining drug quality standards, Himachal Pradesh's Drug Control Administration has taken strict action...

Deaths of Pregnant Women After Administration of Contaminated Ringer's Lactate Solution: CDSCO Under Scanner

Farhat Nasim5 Dec 2024 5:57 PM IST

New Delhi: The Central Drugs Standard Control Organisation (CDSCO) is under scrutiny as the Karnataka government seeks clarification regarding reports...

AstraZeneca Imfinzi based perioperative regimen recommended for approval in EU for resectable non-small cell lung cancer

AstraZeneca Estimates Rs 35 Crore Tax Benefit After ITAT Remands Transfer Pricing Issues

Farhat Nasim4 Dec 2024 6:32 PM IST

New Delhi: AstraZeneca Pharma India Limited has estimated a potential tax benefit of approximately Rs 35 crore following a favorable ruling from...

ASCI Flags 233 Health Ads for DMR Act Violation, Reports to AYUSH Ministry

Six Pharma Suppliers Blacklisted in Five Years for Failing Quality Standards: MoS Anupriya Patel

Farhat Nasim4 Dec 2024 5:00 PM IST

New Delhi: Over the last five years, six pharmaceutical suppliers have been blacklisted for providing substandard medicines to Jan Aushadhi Kendras...

CDSCO Panel Asks Glenmark To Justify BE Waiver for FDC Inhalation Suspension With Scientific Evidence

Glenmark's Win: NPPA revises price of Telmisartan, Cilnidipine FDC after data review

Farhat Nasim3 Dec 2024 2:57 PM IST

New Delhi: Drug maker, Glenmark Pharmaceuticals' appeal against the earlier price fixation for its cardiovascular drug combination, Cilnidipine 20 mg...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok